Hydroxyurea inhibits thymidine kinase activity in developing rat cerebellum

Biochemistry International
|April 1, 1983
PubMed

Insights

Hydroxyurea significantly inhibits thymidine kinase in rat cerebellum, suggesting broader DNA synthesis interference beyond ribonucleotide reductase. This effect is dose and time-dependent, observed in vivo but not in vitro.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Neuroscience

Background:

  • Hydroxyurea is known to inhibit DNA synthesis.
  • Its primary mechanism is often attributed to ribonucleotide reductase inhibition.
  • The role of other enzymes in hydroxyurea's effects is less understood.

Purpose of the Study:

  • To investigate the effect of hydroxyurea on thymidine kinase activity in the rat cerebellum.
  • To determine if hydroxyurea's inhibition of DNA synthesis involves thymidine kinase.
  • To explore the dose and time dependency of hydroxyurea's inhibitory effects in vivo.

Main Methods:

  • Intraperitoneal injection of hydroxyurea in rats (single or three daily doses).
  • Assay of thymidine kinase activity in cerebellar tissue on the 7th day post-injection.
  • In vitro testing of hydroxyurea's effect on thymidine kinase activity.

Main Results:

  • Hydroxyurea markedly inhibited cerebellar thymidine kinase activity.
  • The inhibition was dose-dependent and time-dependent.
  • No inhibitory effect was observed when hydroxyurea was added directly to the reaction mixture in vitro.

Conclusions:

  • Hydroxyurea's inhibition of DNA synthesis may involve mechanisms beyond ribonucleotide reductase.
  • Thymidine kinase is a potential target for hydroxyurea's inhibitory action in vivo.
  • The in vivo versus in vitro discrepancy suggests complex cellular interactions.